Contract Service Directory

Scorpius BioManufacturing

Company Headquarters

1305 East Houston Street
San Antonio, TX 78205
United States

View Phone No.

Visit Website

Request More Info

Contract Service Directory

Content From Scorpius BioManufacturing

A CDMO's Mission To Empower Emerging Biotechs

A global pandemic magnified the need for more biologics manufacturing capacity. Capacity, however, isn’t the whole story.

Sponsored Content Released on 01.15.2024
Does Your Biologics CDMO Truly Have A Culture Of Quality?

What is a culture of quality, and how do you know if a biologics CDMO can earnestly make this claim?

Sponsored Content Released on 01.15.2024
The Bioanalytical Development Journey

As the number of new companies in biopharma continues to grow, so does their demand for outsourcing at every level of biopharmaceutical development.

Sponsored Content Released on 01.15.2024
ABC: Analytics For Biomanufacturing

Samir Lakhashe, Director, Bioanalytical Sciences, discusses assay categorization, the company's growing toolbox, predictions for the future, and more.

Sponsored Content Released on 01.15.2024
Report: Trends Shaping the Future of Emerging Biotechs

100 subject matter experts were surveyed from smaller biotech innovators to gain insight into the dynamics and drivers of the current biologics market.

White Papers / Tech Papers Released on 01.11.2024
Biologics, Proteins, Vaccines | R&D

An Experienced CDMO Can Be A Differentiator In The Rapidly Growing Biologics Market

The demand for biologic drugs continues to grow at a steady 12–14% annually.

Sponsored Content Released on 01.11.2024
Why Process Matters: How Biologics Process Development Can Accelerate Your Path To Market

Biologics process development is an active undertaking that seeks continuous improvement along the entire length of the drug development timeline.

Company Blog Released on 01.11.2024
What Does It Take To Be A Biologics CDMO That Can Serve Today's Mammalian Clinical Mfg Needs?

Clinical manufacturing of cGMP-compliant mammalian cell culture processes is a complex and resource-intensive effort that presents several challenges.

Company Blog Released on 01.11.2024
How a Biologics CDMO Adds Value to mAbs Development & Manufacturing Programs

A look at a CDMO’s value throughout a monoclonal antibody (mAb) therapeutic's lifecycle.

Infographics Released on 01.11.2024
Facility Overview: Scorpius BioManufacturing

Scorpius BioManufacturing is a boutique, US-based biologics CDMO with available capacity for mammalian, cell therapy, and microbial-based programs.

Videos Released on 01.10.2024
Top 6 Questions To Ask When Evaluating A Biologics CDMO

The biologics CDMO selected for a given product or program is critical to an innovator’s ability to deliver a drug product safely, on time, and on budget.

Company Blog Released on 01.10.2024
5 New Questions to Ask Before Signing with a Biologics CDMO

The value biologics CDMOs provide their innovator customers has changed radically in recent years, presenting new questions that must be answered.

Company Blog Released on 01.10.2024
Evaluating Biologics CDMOs: Tips For Crafting An RFP

While crafting a RFP to capture the information innovators need to select a CDMO partner has always been critical; it has grown increasingly complicated.

Company Blog Released on 01.10.2024
How To Select The Right Biologics CDMO Partner

When selecting a biologics CDMO partner—whether you need mammalian or microbial capabilities—the decision-making process follows a similar process.

Company Blog Released on 01.10.2024
Fina Biosolutions Selects Scorpius BioManufacturing for Production of cGMP CRM197

The partnership includes recovery and downstream process optimization, analytical method implementation and phase-appropriate validation, and more.

News Releases Released on 01.10.2024